Clinical Trial Update: A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I, single-center trial evaluating the safety and tolerability of PDC-APB in healthy volunteers has been completed, with contact dermatitis listed as the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Dermatitis

Drugs mentioned

• PDC-APB (PDC-APB)

Snippet

Sponsor: Hapten Sciences, Inc. | Conditions: Contact Dermatitis | Phase 1 | Status: COMPLETED